Sign In
Buy DBVT
$13.63
-0.230 (-1.66%)
At Close: Jul 24, 2026
Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices finished the day higher, with the technology-heavy NAS
Châtillon, France, November 11, 2025 DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN ® Peanut Patch in Peanut Allergic Children Aged 4-7 Years Co
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
04:30pm, Tuesday, 04'th Nov 2025
Châtillon, France, November 4, 2025 DBV Technologies to Participate in the Guggenheim 2 nd Annual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq St
DBV Technologies (DBVT) Expected to Announce Quarterly Earnings on Wednesday
03:02am, Tuesday, 04'th Nov 2025
DBV Technologies (NASDAQ: DBVT - Get Free Report) is projected to issue its Q3 2025 results before the market opens on Wednesday, November 5th. Analysts expect the company to announce earnings of ($1.
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
04:30pm, Monday, 03'rd Nov 2025
Chatillion, France, November 3, 2025 DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: D
Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?
11:36am, Friday, 31'st Oct 2025
Here is how DBV Technologies S.A. (DBVT) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
04:30pm, Thursday, 30'th Oct 2025
Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT),
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
03:00am, Thursday, 30'th Oct 2025
Châtillon, France, October 30, 2025 DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DB
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
06:47pm, Wednesday, 29'th Oct 2025
Châtillon, France, October 29, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR
Strength Seen in DBV Technologies (DBVT): Can Its 6.8% Jump Turn into More Strength?
10:21am, Friday, 17'th Oct 2025
DBV Technologies (DBVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
05:02pm, Monday, 06'th Oct 2025
Châtillon, France, October 6, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0
Peanut allergy is a growing health concern, especially in children, with rising incidence and increased public awareness of its severity and risks. This
New Strong Sell Stocks for September 23rd
06:06am, Tuesday, 23'rd Sep 2025
ATS, ASRT and DBVT have been added to the Zacks Rank #5 (Strong Sell) List on September 23, 2025.
DBV Technologies Announces Resignation of Board Member
04:30pm, Thursday, 18'th Sep 2025
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
04:30pm, Friday, 05'th Sep 2025
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the
